Ultrastructural hepatic changes following the administration of benzylideneyohimbol.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001555:Benzene Derivatives / Q000494:pharmacology; D004285:Dogs; D004721:Endoplasmic Reticulum / Q000187:drug effects; D005260:Female; D006984:Hypertrophy; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008297:Male; D008854:Microscopy, Electron; D008930:Mitochondria, Liver / Q000187:drug effects; D051381:Rats; D046948:Secologanin Tryptamine Alkaloids / Q000494:pharmacology*; D013045:Species Specificity
D000893:Anti-Inflammatory Agents; D001555:Benzene Derivatives; D046948:Secologanin Tryptamine Alkaloids